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Illness perceptions of Libyans with T2DM and their
influence on medication adherence: a study in a diabetes
center in Tripoli
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Background: The surrounding environment influences the constitution of illness perceptions. Therefore, local
research is needed to examine how Libyan diabetes patients perceive diabetes and how their perceptions
influence their medication adherence.
Methods: A cross-sectional study was conducted at the National Centre for Diabetes and Endocrinology in
Tripoli, Libya, between October and December 2013. A total of 523 patients with type 2 diabetes participated
in this study. A self-administered questionnaire was used for data collection; this included the Revised Illness
Perception Questionnaire and the eight-item Morisky Medication Adherence Scale.
Results: The respondents showed moderately high personal control and treatment control perceptions and
a moderate consequences perception. They reported a high perception of diabetes timeline as chronic and a
moderate perception of the diabetes course as unstable. The most commonly perceived cause of diabetes was
Allah’s will. The prevalence of low medication adherence was 36.1%. The identified significant predictors
of low medication adherence were the low treatment control perception (p0.044), high diabetes identity
perception (p0.008), being male (p0.026), and employed (p0.008).
Conclusion: Diabetes illness perceptions of type 2 diabetic Libyans play a role in guiding the medication
adherence and could be considered in the development of medication adherence promotion plans.
Keywords: diabetes; illness perceptions; medication adherence; Arabs; Libya
*Correspondence to: Sana Taher Ashur, Department of Community Health, Universiti Kebangsaan
Malaysia Medical Centre, Jalan Yaacob Latif, Bandar Tun Razak, Cheras, 56000 Kuala Lumpur, Malaysia,
Email: drsana04@yahoo.com
Received: 17 September 2015; Revised: 23 November 2015; Accepted: 30 November 2015; Published: 28 December 2015
D
iabetes is a major global health issue. The Middle
East and North Africa (MENA) region faces the
highest burden of this disease. Compared to the
other world regions, this region has the highest compara-
tive prevalence of diabetes (1). Libya is one of the MENA
countries, with a comparative prevalence of diabetes of
9.86% (1). Medication adherence is important in diabetes
management and studies have supported its relevance
in achieving good glycemic control (2, 3). Despite its
importance, the reported data on adherence to oral
diabetes medications and insulin showed that low medica-
tion adherence is prevalent (4). The issue of low ther-
apeutic adherence in chronic diseases is generally greater
in developing countries than in developed countries (5).
In Libya, a previous study among diabetics at Benghazi
Diabetes Centre reported a considerable rate of subopti-
mal medication adherence (6), and a more recent study in
the same center found that non-adherence to diabetes
management advice as measured by glycosylated hemo-
globin level was considerable (7). Therefore, there is a need
to identify the factors that could influence medication
adherence among Libyan diabetic patients.
Illness perceptions are among the modifiable factors
that have been postulated to influence coping behaviors
in illness. Therefore, studying them might help in under-
standing medication adherence among diabetics. This post-
ulation has been presented by the Common Sense Model
(CSM) of illness perceptions (8, 9). The CSM demon-
strates the role of cognitive perceptions as well as the
emotional representations of the illness in guiding human
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coping behaviors (8, 9). Several studies have shown that
CSM illness perceptions influence coping behaviors in
diabetes (1014) and in other chronic diseases (15). In
illness perception research, it is important to consider the
context of the study population, because the surrounding
atmosphere is one of the important sources of information
that influences the constitution of illness perceptions (8, 9).
The patient gathers information from several sources
and processes them into illness perception constitutions.
Among these sources of information is the personal con-
text, like the patient’s own memories about a previous
illness experience, and also the interpersonal context and
the surrounding environment (8). Therefore, different
populations might constitute different perceptions about
the same illness. Several studies have shown the differences
in illness perceptions across different groups, both in
diabetes (11, 16, 17) and other diseases (15).
Thus, to have a valid insight on how Libyan diabetics
perceive their diabetes and how their perceptions influence
their medication adherence, it is important to conduct
local research. To the best of our knowledge, there has
been no previous study on this topic in Libya. Overall,
there is a paucity of research that relates psychological
factors to patient behavior in the Libyan diabetes context.
We identified one study that related self-efficacy  which
is a close concept to one of the CSM illness perceptions,
the personal control perception  to non-adherence to
diabetes management advice (7). The aim of our paper was
to assess diabetes illness perceptions among Libyans with
type 2 diabetes mellitus (T2DM) and the influence of their
diabetes perceptions on their medication adherence.
Materials and methods
Study settings and participants
This study was part of a larger study that looked at several
outcomes, including diabetes coping behaviors and gly-
cemic control status of T2DM patients. The study design
was cross-sectional and it was conducted at the National
Centre for Diabetes and Endocrinology (NCDE) in Tripoli,
Libya, after being approved by Universiti Kebangsaan
Malaysia Research and Ethics Committee and the man-
agement at the NCDE. The NCDE, although a referral
center, provides diabetes follow-up, medications, and
laboratory services for diabetes outpatients.
To find out the minimum sample size required for the
large study, several calculations were performed. The
largest sample size obtained was considered, and it was
based on the sample size needed to test the difference in
the prevalence of poor glycemic control across males and
females using the Fleiss formula (18). The preliminary
data used in the calculation included a prevalence of poor
glycemic control among males of 45% and among females
of 58% (19). A sample size of 498 was needed for a margin
of precision (a) of 5% and a power of 80%. To compensate
for low response and rejection due to non-eligibility,
30% was added. Thus, the target sample size was 648
respondents.
Patients were recruited systematically at the laboratory
waiting area between October and December 2013, where-
by every fourth patient was approached at their coming
sequence. When the patient was not eligible, the immediate
next patient was invited. The eligibility criteria included
being Libyan, having T2DM for at least 1 year, being
18 years old or above, having no cognitive impairment
that could interfere with communication or comprehend-
ing the questions, being able to read and write in Arabic,
having no visual impairment that interfered with self-
reporting, and being willing to participate in the study.
Those who were placed on a diet plan only, pregnant
women, and very ill patients were not eligible. The type
of diabetes was self-reported, and it was verified whenever
applicable by checking the medical follow-up card of
each respondent. However, as not all the follow-up cards
showed the type of diabetes, further verification of dia-
betes type was done at the stage of analysis. Those who
reported being diagnosed before the age of 40, placed on
insulin at diagnosis, and on insulin at the time of the study
(20) were considered as having type 1 diabetes and were
excluded from the analysis. Out of the 648 addressed
patients, 523 responses were considered in the data
analysis, which gave a response rate of 80.7%. Details on
sampling flow are depicted in Fig. 1. Patients were given a
briefing about the study, as well as on their participation
and withdrawal rights. The study was conducted on a
voluntary basis and consent forms were received.
Measures
Data collection was based on a self-reported question-
naire, which gathered information about patients’ socio-
demographic characteristics and disease profile, their
diabetes illness perceptions based on the Revised Illness
Perception Questionnaire (IPQ-R), and medication ad-
herence based on the eight-item Morisky Medication
Adherence Scale (MMAS-8).
Data on age, sex, marital status, education level,
employment status, income, duration of diabetes, type of
diabetes medication, presence of comorbidity, and the
number of other medications were gathered from the
information sheet.
The Revised Illness Perception Questionnaire
The IPQ-R was used with permission to assess
diabetes illness perceptions. A version for diabetes
is available at the IPQ website. The IPQ-R is a well-
validated instrument (21). It includes three sections.
The first section represents the identity perception
domain and comprises 14 listed symptoms. Each
symptom is attached to a yes or no response. Identity
perception refers to how the patient labels the illness.
Sana Taher Ashur et al.
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It is related to the number of symptoms the patients
have experienced since their diabetes diagnosis and
that they attribute to their diabetes. A high score
indicates a high diabetes identity perception. The
second section comprises 38 items and measures seven
illness perception domains (timeline acute/chronic
perception, timeline cyclical perception, consequences
perception, personal control perception, treatment
control perception, illness coherence, emotional
representations). Each of the 38 items is attached to
a five-level (strongly disagree  strongly agree) Likert-
type response. Timeline acute-chronic perception (six
items) refers to the perception of the illness duration.
A high score indicates a strong perception of diabetes
as a chronic (long-term) illness (sample item: ‘My
diabetes will last a short time’). Timeline cyclical
perception (four items) refers to the perception of the
pattern of the course of the illness. A high score
indicates a strong perception of diabetes course as a
cyclical or unstable illness (sample item: ‘I go through
cycles in which my diabetes gets better and worse’).
Consequences perception (six items) refers to the
perception of the seriousness of the illness and its
impact on life. A high score indicates a perception of
diabetes as a serious illness with negative impacts on
life, social relationships, or economic status (sample
item: ‘My diabetes is a serious condition’). Personal
control perception (six items) refers to the patient’s
perception of his or her own ability to manage or
control the illness. A high score indicates a high
perception of the personal ability to control diabetes
(sample item: ‘I have the power to influence my
diabetes’). Treatment control perception (five items)
refers to the perception of the effectiveness of
treatment in controlling the illness. A high score
indicates a high perception of the effectiveness of
diabetes treatment in controlling diabetes (sample
item: ‘My treatment can control my diabetes’). Illness
coherence (five items) refers to the patient’s percep-
tion of his or her own understanding of the illness.
A high score indicates a high perception of the
personal understanding of diabetes and that diabetes
is perceived as a clear or unambiguous illness (sample
item: ‘I have a clear picture or understanding of my
condition’). Emotional representations (six items)
refer to emotional responses to the illness. A high
score refers to more emotional responses to diabetes
and indicates that diabetes affects the patient emo-
tionally and makes him or her emotionally distressed
(sample item: ‘When I think about my diabetes I get
upset’). The last section of the IPQ-R is the cause
section, and it comprises 18 disparate items (causes).
Each item is attached to a five-level (strongly disagree
 strongly agree) Likert-type response. We dichoto-
mized the responses to each cause item into yes and
no, where yes indicated those who strongly agreed or
agreed on the item as a cause for their diabetes (22).
Only the eight illness perception domains (identity
perception, timeline acute-chronic perception, time-
line cyclical perception, consequences perception,
personal control perception, treatment control per-
ception, illness coherence, emotional representa-
tions) were defined as independent variables and
tested for their contribution to medication adherence,
whereas the cause section was only included for
description. The scale was translated from English
into Arabic by two bilingual translators using a
forwardbackward method. The content validity of
the scale was assessed by a group of Libyan experts,
and two items were added to the other 14 generic
symptoms in the identity subscale numbness and
paresthesia. Another item was added to the 18
disparate items in the cause section  Allah’s will or
fate. Then, face validity was pretested on 10 diabetic
Libyans and the necessary amendments to enhance
the clarity were done.
The eight-item Morisky Medication Adherence Scale
The MMAS-8 was used to measure medication adherence.
It is a valid (23, 24) single-dimension measure that com-
prises eight items (sample item: ‘When you travel or leave
home, do you sometimes forget to bring along your medi-
cations?’). Each item is attached to a yes or no response,
n=648 (100%)
n=566 (87.34%)
Distributed questionnaires
n=551(85.03%)
Received questionnaires
n=26 (4.01%)
Largely incomplete questionnaires
Excluded
n=15 (2.31%)
Not returned
n=82 (12.65%)
Non-eligible
-Not welling to participate
-Unable to independently complete
the questionnaire (cannot read or
write, low visual equity).
-Others:
On diet plan
Newly diagnosed (<1 year)
Not Libyans
<18 years old
TIDM
Pregnancy
n=525 (81.01%)
Received complete questionnaires
Considered for data entry
n=523 (80.7%)
Received complete questionnaires
Considered for analysis
n=2 (0.30%)
Probably T1DM
Excluded
Fig. 1. Sampling flowchart.
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except for the last item, which has a five-level Likert-type
response (23). The short construct of the MMAS-8 was
useful as data were collected in a busy clinical setting (25).
The possible total score range is from 0 to 8. A score
of 8 indicates high adherence, a score of 6 and above
but less than 8 indicates moderate adherence, whereas a
score below 6 indicates low adherence (23, 24). An Arabic
version was obtained with permission from the scale
copyright owner. This version was found to be reliable
and valid among Libyans with T2DM (26).
Data analysis
Data analysis was conducted using SPSS (version 22)
for Windows. The internal consistency reliability of the
IPQ-R and MMAS-8 was assessed using Cronbach’s alpha.
A chi-square test, independent t-test, and the Mann
Whitney U test were used to explore the bivariate
associations between medication adherence and socio-
demographic characteristics, disease profile, and illness
perceptions. All variables that showed bivariate associa-
tions with medication adherence at a p-value of 0.25
or less were included in the multiple regression analysis.
A two-step hierarchical binary multiple logistic regression
was run to test the contribution of illness perceptions on
low medication adherence. A p-value less than 0.05 was
considered in the interpretation of the significance of the
findings.
Results
Table 1 summarizes the sociodemographic characteristics
and disease profile of the respondents. The mean age of
the respondents was 54.43 (SD10.03). The mean diabetes
duration was 9.4 (SD7.3) years, and the number of
other long-term medications ranged from zero to seven.
Table 2 displays the descriptive statistics of diabetes
illness perceptions based on the identity and views sections
of the IPQ-R. All eight illness perception domains dis-
played a satisfactory internal consistency, with the alpha
coefficient ranging from 0.87 for the emotional representa-
tions subscale to 0.76 for the consequences perception
subscale. Respondents showed low diabetes identity per-
ception, indicating that they attributed few of the symp-
toms they experienced to their diabetes (mean4.55,
SD3.72). They showed a high perception of diabetes
timeline as a chronic illness (mean22.08, SD5.34) and
a moderate perception of diabetes course as a cyclical
(unstable) illness (mean12.42, SD4.80). Illness coher-
ence was moderate (mean16.12, SD6.76). Respon-
dents had a moderately high perception of the treatment
controllability of their illness (mean19.19, SD4.48)
and their personal control over diabetes (mean18.93,
SD7.06), while demonstrating a moderate diabetes con-
sequences perception (mean16.24, SD6.05) and emo-
tional representations (mean16.99, SD7.76).
Table 3 shows the descriptive statistics on the percep-
tions of the cause of diabetes. The five most commonly
indicated causes out of the 19 listed items as causes for
diabetes were ‘Allah’s will/fate’ (86.6%), ‘hereditary  it
runs in my family’ (53.0%), ‘my emotional state’ (44.4%),
‘family problems or worries’ (40.0%), and ‘diet or eating
habits’ (35.6%).
Table 4 shows the descriptive statistics on diabetes
medication adherence based on the MMAS-8. The scale
showed a satisfactory internal consistency reliability
(a0.74). The mean medication adherence score was
6.06 (SD1.89), and the prevalence of low medication
adherence was 36.1%.
Table 5 shows the results of bivariate analysis. Several
sociodemographic variables and disease profilerelated
factors showed statistically significant associations with
medication adherence. The frequency of low medication
adherers was significantly higher among males than females
(x210.247, p0.001). Respondents with secondary to
high education level reported a significantly higher pre-
valence of low medication adherers than those with
primary education (x25.628, p0.018). A significantly
higher frequency of low adherers was also found among
employed respondents compared to the unemployed
(x217.921, pB0.001) and among the moderate- to
Table 1. Sociodemographic characteristics and disease
profile (n523)
Variable f %
Sex
Male 215 41.1
Female 308 58.9
Marital status
Not married 121 23.1
Married 402 76.9
Education level
Primary 304 58.1
Secondary or higher 219 41.9
Employment status
Employed 142 27.2
Unemployed 381 72.8
Income (LD)a
Low (600 and less) 394 75.3
Moderate-high (more than 600) 129 24.7
Diabetes medications
OHGb 199 38.0
Insulin with or without OHGb 324 62.0
Comorbidity
No 215 41.1
Yes 308 58.9
aLD, Libyan dinars (conversion rate at the time of the study:
1 LD1.32 USD).
bOHG, oral hypoglycemic agents.
Sana Taher Ashur et al.
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high-income group compared to the low income group
(x23.925, p0.048). Respondents who had no comor-
bidity showed a significantly higher prevalence of low
medication adherers compared to those who had comor-
bidity (x211.466, p0.001). In addition, there was
a significant difference in the number of other long-term
medications between low adherence and moderate-high
adherence groups (z2.810, p0.005). Regarding
illness perceptions, a significant difference in the mean
treatment control perception score (t2.366, p0.018)
was found between patients who reported low adherence to
their diabetes medications (mean18.58, SD4.51) and
those who reported moderate-high adherence (mean19.54,
SD4.44).
Table 6 shows a two-step hierarchical binary logistic
regression model. In the first step, all sociodemographic
and disease profilerelated factors that displayed associa-
tions with medication adherence at p50.25 in the
bivariate analysis were entered into the model. All illness
perceptions that displayed crude associations with med-
ication adherence with p50.25 were entered in the second
step. In the first step, the model showed a good fit of
the included variables as indicated by the non-significant
Hosmer Lemeshow test (p0.160). Referring to the
block omnibus test, the contribution of the model with
these variables to low medication adherence variance
compared to the model with the constant alone was
significant (Dx2 (df) 26.997(8), p0.001). Based on the
Nagelkerke R2, this model contributed to 6.9% of the
variance of low medication adherence. In the second step,
illness perceptions were added to the model. The model
showed a good fit of the included variables as indicated
by the non-significant HosmerLemeshow test (p0.208).
The addition of illness perceptions led to a significant
improvement in the model’s level of predictivity as
indicated by a significant chi-square increment (Dx2 (df)
19.867(5), p0.001). Referring to the Nagelkerke
R2, the model’s level of predictivity was raised to 11.7%.
Thus, illness perceptions have a unique contribution
to medication adherence above and beyond the control
variables alone.
The final model showed that two illness perceptions
contributed significantly to low medication adherence;
these were treatment control perception and illness identity
perception. High treatment control perception contributed
slightly yet significantly to medication adherence as a
protective factor. The odds of having low adherence to
medications decreased with the increase in treatment
control perception (p0.044, OR0.95, 95% CI
0.91_0.99). On the other hand, high identity perception
predicted lower medication adherence, as the odds of
having low adherence to medications increased with the
increase in identity perception (p0.008, OR1.08, 95%
CI1.021.14). Two of the control variables also dis-
played a significant contribution to low medication
Table 2. Diabetes illness perceptions based on the Revised Illness Perception Questionnaire (IPQ-R) scale
IPQ-R Number of items Possible score range Mean9SD Cronbach’s alpha (a)
I Identity 16 016 4.5593.72 0.841
II Timeline (acute/chronic) 6 630 22.0895.34 0.788
III Timeline (cyclical) 4 420 12.4294.80 0.772
VI Consequences 6 630 16.2496.05 0.763
V Personal control 6 630 18.9397.06 0.793
VI Treatment control 5 525 19.1994.48 0.780
VII Emotional 6 630 16.9997.76 0.877
VIII Coherence 5 525 16.1296.76 0.847
Table 3. Diabetes cause perceptions (n523)
Causea
Strongly agree or agree
f (%)
1. Allah’s will/fate 86.6
2. Hereditary  it runs in my family 53.0
3. My emotional state 44.4
4. Family problems or worries 40.0
5. Diet or eating habits 35.6
6. My own behavior 31.9
7. My mental attitude 29.1
8. Chance or bad luck 23.9
9. Poor medical care in my past 23.5
10. Stress or worry 21.8
11. My personality 14.1
12. Overwork 14.0
13. Accident or injury 11.5
14. Aging 1.3
15. A germ or virus 0.8
16. Pollution in the environment 0.6
17. Altered immunity 0.4
18. Alcohol 0.0
19. Smoking 0.0
aThe cause section of the IPQ-R consists of disparate items.
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adherence; these were sex and employment status. Females
were 1.5 times less likely than males to be low adherers
(p0.026, OR0.59, 95% CI0.370.93) and unem-
ployed respondents were half as likely as employed
respondents to be low adherers (p0.008, OR0.45,
95% CI0.250.81).
Discussion
To the best of our knowledge, this study was the first to
explore diabetes perceptions as guided by the CSM in the
Libyan context. In our study, the number of female
respondents exceeded that of males. Although this might
indicate that females were more willing to participate
in the study, it may also reflect the sex profile of diabetes
in Libya. An early study of the epidemiological pattern
of diabetes in Benghazi, Libya, found that the prevalence
of T2DM was significantly higher among females than
males (27). The predominance of females over males was
also reported in a previous study among diabetics in the
same center where our study was conducted (28) and in
other Libyan diabetes settings (6, 7). The respondents
reported a low identity perception, indicating that they
attributed few of the symptoms they had experienced
after the diagnosis to their diabetes. Regarding personal
and treatment control perception domains, the respon-
dents reported a moderately high perception of both their
own ability to control their diabetes and the effectiveness
of their diabetes treatment. Personal control perception is
a close concept to self-efficacy, which is also about the
confidence of the patients in their personal ability to
control their illness. In line with our finding, a previous
study among adult diabetics in Libya reported a moder-
ate level of self-efficacy (7). The respondents perceived
diabetes as a chronic illness, and moderately perceived the
course of diabetes as unstable or cyclical. The respon-
dents reported moderate coherence perception, which
reflects a moderate personal understanding of diabetes.
This finding shows that many of them perceived diabetes
as an ambiguous illness that they did not understand
well. Lack of professional information on diabetes, which
in turn affects diabetes knowledge, could be one of the
reasons. Several previous studies in the Libyan diabetes
context showed a poor level of diabetes knowledge (6, 7).
Therefore, empowering our patients’ diabetes knowledge
through diabetes educational programs could help in
optimizing their diabetes coherence or understanding
perception. The respondents perceived that diabetes im-
posed moderate consequences on their life and health and
they displayed moderate negative emotional responses to
their illness.
The Islamic religious influences on the constitution
of diabetes perceptions were reflected in the perception
of the cause of diabetes, where ‘Allah’s will/fate’ was
the most frequently reported cause for diabetes. We also
found that more respondents attributed their diabetes to
psychosocial factors like their emotional state and family
problems or worries than to their diet or eating habits.
Studies in other diabetic populations reported different
cause perception patterns. For instance, in a study among
Nepali diabetics, pollution and immunity were frequently
reported as the causes of diabetes, whereas emotional
state was among the least perceived causes (22). Further-
more, a study in the United States reported heredity, diet
and eating habits, and own behavior as the top three
perceived causes for diabetes (14).
More than one-third of the respondents reported low
adherence to their diabetes medications. This is consider-
able, and it should be taken seriously for its consequences
on patients’ health and its ultimate impacts on the health-
care system. Our study confirmed the findings of two
previous studies in the Libyan diabetes context (6, 7). In
a large diabetes care center in Benghazi, Libya, Roaeid
and Kablan (6) reported that 27.1% of diabetics were
not taking their medications regularly. In a more recent
study in the same center in Benghazi, Elkharam et al. (7)
assessed adherence to diabetes management advice using
HbA1c as a distant adherence measure, and their findings
also reflected the problem of low adherence levels. Both of
these two studies used different adherence measures to
that used in this current study. Compared to some Middle
Eastern countries, the reported low medication adherence
prevalence in this study is lower than that reported in
Palestine among T2DM patients, using the same measure
(42.7%) (29), but higher than that reported in Jordan (30).
Table 4. Medication adherence based on the MMAS-8#
Medication adherence level f (%) a
Total score (mean9SD) 6.06 91.89 0.72
Medication adherence groups
Low (scoreB6) 189 36.1
Moderate and high (score ]6) 334 63.9
Use of the #MMAS is protected by US copyright laws. Permission for use is required. A license agreement is available from: Donald E.
Morisky, ScD, ScM, MSPH, Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young
Drive South, Los Angeles, CA 90095-1772; dmorisky@ucla.edu.
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In this study, we focused on eight illness perception
domains in relation to medication adherence. Our find-
ings added to the preexisting research evidence on the role
of the CSM illness perceptions in guiding the coping
behaviors in illness (1014). Two illness perceptions were
found to contribute significantly to medication adherence;
these were identity and treatment control perceptions.
The contribution of each of these two perceptions
matched the theoretically anticipated directions. Identity
perception was a predictor factor. The respondents who
attributed many of the symptoms they had experienced
to their diabetes were more likely to be low adherers to
their medications. Meanwhile, treatment control percep-
tion was a protective factor, as those who reported higher
perception of the effectiveness of their treatment were less
likely to be low adherers. In line with our findings, it was
found that the perceived treatment effectiveness in dia-
betes control contributed to the use of insulin (31).
Table 5. Bivariate association between sociodemographic factors, disease profile, and illness perceptions with medication
adherence
Medication adherence
Moderate-high adherence Low adherence
Variables f (%) f (%) f (%) f (%) x2 P
(I) Sociodemographic
Age (mean9SD) 54.84 910.09 53.69 99.91 1.261a 0.208
Sex
Male 120 (55.8) 95 (44.2)
Female 214 (69.5) 94 (30.5) 10.247 0.001**
Marital status
Unmarried 84 (69.4) 37 (30.6)
Married 250 (62.2) 152 (37.8) 2.108 0.147
Education level
Primary 207 (68.1) 97 (31.9)
Secondary or higher 127 (58.0) 92 (42.0) 5.628 0.018*
Employment status
Employed 70 (49.3) 72 (50.7)
Unemployed 264 (69.3) 117 (30.7) 17.921 0.000***
Income (Libyan dinar)
Low (600 or less) 261 (66.2) 133 (33.8)
Moderate-high (more than 600) 73 (56.6) 56 (43.4) 3.925 0.048*
(II) Disease profile
Diabetes duration (years) 9.72 97.56 9.04 96.83 1.058 0.291
Diabetes medications
OHG 126 (63.3) 73 (36.7)
Insulin9OHG 208 (64.2) 116 (35.8) 0.041 0.839
Comorbidity
No 119 (55.3) 96 (44.7)
Yes 215 (69.8) 93 (30.2) 11.466 0.001**
Number of other medications (mean9SD) 0.98 91.15 0.72 91.04 2.810b 0.005**
(III) Illness perceptions (mean9SD)
Identity 4.33 93.62 4.93 93.86 1.772 0.077
Timeline (acute/chronic) 22.19 95.39 21.90 95.27 0.594 0.553
Timeline (cyclic) 12.19 94.87 12.81 94.65 1.428 0.154
Consequences 15.99 96.04 16.69 96.05 1.276 0.202
Personal control 19.05 97.18 18.71 96.86 0.527 0.599
Treatment control 19.54 94.44 18.58 94.51 2.366 0.018*
Emotional 16.53 97.70 17.81 97.84 1.825 0.069
Coherence 16.11 96.90 16.14 96.52 0.052 0.959
*pB0.05, **pB0.01, ***pB0.001.
at statistic (independent t-test); bz statistic (MannWhitney U test).
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Although treatment control perception was identified
among the predictors of medication adherence among
Nepali diabetics, unlike in our study, higher perception of
treatment effectiveness was associated with lower medica-
tion adherence (22).
The final model also identified two personal character-
istics as predictors of low medication adherence; these
were sex and employment status. Females were less likely
than males to have low adherence to their diabetes medi-
cations. This was inconsistent with the findings of some
studies where no relationship between sex and adherence
level was reported (29, 32). Employed respondents were
more likely to have low adherence than employed re-
spondents. This could be related to some barriers that
Table 6. Hierarchical regression model of low medication adherence predictors
Model 1 Model 2
Variables B Wald
Adjusted OR
(95% CI) B Wald
Adjusted OR
(95% CI)
Step 1
Sociodemographic and
disease profile
Age 0.000 0.001 1.00 (0.981.02) 0.004 0.155 1.00 (0.981.02)
Sex
Male (reference)
Female 0.357 2.569 0.70 (0.451.08) 0.522 4.522 0.59 (0.370.93)*
Marital status
Unmarried (reference)
Married 0.054 0.049 1.05 (0.651.69) 0.087 0.123 1.09 (0.671.77)
Education
Primary (reference)
Secondary or higher 0.033 0.021 0.96 (0.621.50) 0.082 0.128 0.92 (0.581.44)
Employment
Employed (reference)
Unemployed 0.646 5.079 0.52 (0.290.91)* 0.781 6.983 0.45 (0.250.81)**
Income
Low (reference)
Moderate-high 0.083 0.098 0.92 (0.541.54) 0.002 0.000 1.00 (0.591.70)
Presence of comorbidity
No (reference)
Yes 0.409 2.902 0.66 (0.411.6) 0.419 2.858 0.65 (0.401.06)
Number of other
medications
0.035 0.100 0.96 (0.771.19) 0.081 0.515 0.92 (0.731.15)
Constant 0.327 0.230 1.38
Step 2 Illness perceptions
Identity 0.078 7.059 1.08 (1.021.14)**
Timeline (cyclical) 0.027 1.509 1.02 (0.981.07)
Consequences 0.001 0.001 0.99 (0.961.03)
Treatment control 0.044 4.074 0.95 (0.910.99)*
Emotional 0.010 0.420 1.01 (0.981.04)
Constant 0.298 0.110 1.34
Model fitness
(HosmerLemeshow)
0.160 0.208
Omnibus test
^x2 (df), p 26.997 (8), 0.001** 19.867 (5), 0.001**
x2 (df), p 26.997 (8), 0.001** 46.865 (13), 0.000***
Model predictivity
(Nagelkerke R2)
0.069 0.117
*pB0.05, **pB0.01, ***pB0.001; ^x2, chi-square difference across two subsequent models after adding illness perceptions.
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employed diabetics face, such as the lack of time or access
to medications while away from home. Consistent with our
findings, some other studies found that employment status
influenced medication adherence in diabetes (22, 33).
Several limitations should be considered in the inter-
pretation of the findings from this study, such as the
cross-sectional design, which precludes making causal
assumptions, and self-reporting of data, which is subject
to recall bias as well as over- and under-reporting bias.
Type 2 diabetic Libyans who are unable to read and write
should be considered in further research that uses face-
to-face interviews. As the study was conducted in a
single diabetic center in Tripoli, the findings could not
be generalized to all Libyans with T2DM. However, the
findings could be generalized to the study population,
which is Libyans with T2DM who attended the center
during the study period.
Conclusion
This study provided insight into how Libyans with T2DM
perceive their diabetes. The findings may inform local
diabetic care providers about how their patients perceive
their diabetes. Better understanding of the patients could
positively influence patientprovider communication. The
current study confirmed the suboptimal level of medica-
tion adherence reported by some previous studies in the
Libyan diabetes context. It also showed how diabetes
illness perceptions influence medication adherence. These
findings could be used to develop medication adherence
promotion approaches, as in the form of psychoeduca-
tional interventions. The findings from this study showed
that males and employed patients were more likely to
be low adherers; therefore, they might represent in-need
groups for medication adherence promotion. The predic-
tivity of the medication adherence model was low. Thus,
further research is needed to identify what other factors
could explain low medication adherence among Libyan
diabetics. In addition, as our study was conducted at a
single center, in the capital city of Libya, more research
in the Libyan diabetes context is warranted to support
the generalizability of the findings from our study to all
Libyans with T2DM.
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